0

Potent, Orally Bioavailable Calcitonin Gene-Related Peptide Receptor Antagonists for the Treatment of Migraine: Discovery of N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1- (2,2,2-trifluoroethyl)azepan-3-yl]-4- (2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin- 1-yl)piperidine-1-carboxamide (MK-0974)

Daniel V Paone, Anthony W Shaw, Diem N Nguyen, Christopher S Burgey, James Z Deng, Stefanie A Kane, Kenneth S Koblan, Christopher A Salvatore, Scott D Mosser, Victor K Johnston, Bradley K Wong, Cynthia M Miller-Stein, etc.

J Med Chem. 2007 Nov 15;50(23):5564-7.

PMID: 17929795

Abstract:

Calcitonin gene-related peptide (CGRP) has been implicated in the pathogenesis of migraine. Herein we describe optimization of CGRP receptor antagonists based on an earlier lead structure containing a (3R)-amino-(6S)-phenylcaprolactam core. Replacement of the phenylimidazolinone with an azabenzimidazolone gave stable derivatives with lowered serum shifts. Extensive SAR studies of the C-6 aryl moiety revealed the potency-enhancing effect of the 2,3-difluorophenyl group, and trifluoroethylation of the N-1 amide position resulted in improved oral bioavailabilities, ultimately leading to clinical candidate 38 (MK-0974).

Chemicals Related in the Paper:

Catalog Number Product Name Structure CAS Number Price
AP22753806 2-[N-(2,2,2-Trifluoroethyl)amino]-5-chlorobenzophenone 2-[N-(2,2,2-Trifluoroethyl)amino]-5-chlorobenzophenone 22753-80-6 Price
qrcode